Cargando…
Identification of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA-Seq
BACKGROUND: Alternative splicing isoforms have been reported as a new and robust class of diagnostic biomarkers. Over 95% of human genes are estimated to be alternatively spliced as a powerful means of producing functionally diverse proteins from a single gene. The emergence of next-generation seque...
Autores principales: | Zhang, Fan, Deng, Chris K., Wang, Mu, Deng, Bin, Barber, Robert, Huang, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713335/ https://www.ncbi.nlm.nih.gov/pubmed/33272210 http://dx.doi.org/10.1186/s12859-020-03824-8 |
Ejemplares similares
-
LC and LC–MS/MS studies for the identification and characterization of degradation products of acebutolol
por: Rakibe, Uday, et al.
Publicado: (2018) -
LC-MS/MS Identification of a Bromelain Peptide Biomarker from Ananas comosus Merr
por: Secor, Eric R., et al.
Publicado: (2012) -
Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS/MS
por: Chen, Zhen, et al.
Publicado: (2016) -
Clinical relevance of guanine-derived urinary biomarkers of oxidative stress, determined by LC-MS/MS
por: Shih, Ying-Ming, et al.
Publicado: (2018) -
LC, MS(n) and LC–MS/MS studies for the characterization of degradation products of amlodipine
por: Tiwari, Ravi N., et al.
Publicado: (2015)